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The zebraﬁsh embryotoxicity test (ZET) is a fast and simple method to study chemical toxicity after expo-
sure of the complete vertebrate embryo during embryogenesis in ovo. We developed a novel quantitative
evaluation method to assess the development of the zebraﬁsh embryo based on speciﬁc endpoints in
time, the general morphology score (GMS) system. For teratogenic effects a separate scoring list was
developed. The relative effects of eight glycol ethers and six 1,2,4-triazole anti-fungals were evaluated
in this system and results were compared with in vivo developmental toxicity potencies.
Methoxyacetic acid and ethoxyacetic acid appeared as the most potent glycol ether metabolites,
inducing growth retardation and malformations. Other glycol ethers showed no developmental toxicity.
Flusilazole appeared the most potent triazole, followed by hexaconazole, cyproconazole, triadimefon,
myclobutanil and triticonazole, respectively.
In general, the potency ranking of the compounds within their class in the ZET was comparable to their
in vivo ranking.
In conclusion, the ZET with the GMS system appears an efﬁcient and useful test system for screening
embryotoxic properties of chemicals within the classes of compounds tested. This alternative test
method may also be useful for the detection of embryotoxic properties of other classes of chemicals.
 2011 Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction
A variety of alternative assays for developmental toxicity testing
in animals has been developed over the years, including the zebra-
ﬁsh embryotoxicity test (ZET). This test is gaining popularity, since
it is a unique alternative that enables the study of the initial stages
of a complete andwell characterized developmental period of a ver-
tebrate embryo (Gilbert, 2000; Hill et al., 2005) in a simple and fast
culture system (Kimmel et al., 1995; Nüsslein-Volhard and Dahm,
2002). Alternative low vertebrate whole embryo cultures include
Japanese medaka (Oryzias latipes), fathead minnow (Pimephales
promelas) and Xenopus laevis. Each of these models has their pros
and cons (Braunbeck et al., 2005; Fort and Paul, 2002). Zebraﬁsh em-
bryos develop independently of thematernal ﬁsh, are simply kept in
water and development until hatching takes only three days. All
these advantages make the zebraﬁsh embryo suitable for relatively
high-throughput tests. In addition, at the embryonic stages used inrotection Research, National
IVM), P.O. Box 1, 3720 BA
: +31 30 2744446.
rmsen).
evier OA license.the ZET, zebraﬁsh embryos are not considered as experimental ani-
mals under European legislation (European Commission, 1986).
For evaluation of development and malformations of embryos,
standardization of the scoring system will enhance reproducibility
and thus improve comparison among experimental groups. One of
the current methods is based on the scoring of several develop-
mental and lethal endpoints in a binomial way to derive the EC50
and LC50 (Bachmann, 2002; Braunbeck et al., 2005; Nagel, 2002;
Seok et al., 2008). Additionally, these data can be used to calculate
the teratogenic index to predict the teratogenic potency of the
compound (Nagel, 2002; Selderslaghs et al., 2009; Ton et al.,
2006). However, the endpoints monitored may differ between
studies and are scored as all or nothing events without taking
severity of effects into account. To overcome this problem a more
quantitative method has been introduced by Brannen et al. (2010).
They assigned severity scores for several endpoints. Furthermore,
body length and head–trunk angle were measured, the distance
between eye and otic vesicle was estimated and somite pairs were
counted, which makes this method relatively labor intensive.
In order to improve the standardization of the scoring, we devel-
oped a novel evaluation method for screening zebraﬁsh embryo
development allowing a relatively fast, but semi-quantitative
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used in the rat whole embryo culture (WEC) (Brown and Fabro,
1981). Scores are assigned to readily observable speciﬁc develop-
mental endpoints at different points in time. Speciﬁc teratogenic
effects are separately recorded. This allows us to monitor develop-
mental delay and retardation as well as teratogenicity.
In this study we used our general morphology score (GMS) sys-
tem to evaluate the relative embryotoxic effects of compounds
within two different classes of chemicals to evaluate the applica-
bility of the ZET for these classes of compounds. We compared
the ZET relative potencies within each class with their in vivo
developmental toxicity ranking. This category approach assumes
that if the ranking of the compounds in the ZET corresponds to
the in vivo ranking, there is a high likelihood that the embryotoxic
potency of new compounds within the same class can be predicted
with the test system (de Jong et al., 2009; Hefter et al., 1999).
Both classes of compounds were selected based on the availabil-
ity of in vivo data and the presence of embryotoxic as well as non-
embryotoxic class members. To this end, a series of structural
homologous glycol ether alkoxy acid metabolites and two of their
parent compoundswere tested. Glycol ethers arewidely used as sol-
vents in inks and paints. Some of them have been shown to have
embryotoxic properties after exposure through several routes of
administration inmice, rats and rabbits (Brown et al., 1984; Feuston
et al., 1990; Hanley et al., 1984; Hardin et al., 1984; Nagano et al.,
1981). Embryotoxic effects,mainly causedby ethylene glycolmono-
methyl ether (EGME) and its metabolite methoxyacetic acid (MAA),
and ethylene glycol monoethyl ether (EGEE) and its metabolite eth-
oxyacetic acid (EAA), include visceral and skeletal malformations as
well as resorptions (Hanley et al., 1984; Hardin et al., 1984).
Furthermore, we tested a series of six triazole derivatives. These
compounds are used as fungicides and some of them also exhibit
developmental toxic effects in rats and mice (Farag and Ibrahim,
2007; Machera, 1995; Menegola et al., 2005). These teratogenic ef-
fects include craniofacial and axial skeletal malformations. Speciﬁc
teratogenic effects on the level of the branchial apparatus, such as
reduction, agenesis and fusion between the arches were observed
in rat whole embryo culture (Menegola et al., 2000, 2001) and in
the amphibian X. laevis embryos (Groppelli et al., 2005; Papis
et al., 2006).2. Materials and methods
2.1. Maintenance of ﬁsh and egg spawning
Danio rerio adults were commercially obtained (Ruinemans
Aquarium BV, Montfoort, The Netherlands) and maintained and
bred in our facilities for more than 3 years. Adult zebraﬁsh were
kept in 7.5 l ZebTEC aquaria at 27 C ± 1 C with a photoperiod of
14 h light: 10 h dark. They were fed twice daily with dry ﬂakes
(Special Diet Services, Tecnilab-BMI BV, The Netherlands) and once
daily with defrosted Artemia (Landman BV, The Netherlands) in a
quantity that was consumed within 5 min. Three days before
spawning, females were separately housed and fed only thawed
Artemia, both to optimize egg production. Males and females were
paired in spawning boxes the day before spawning in a ratio of 2:2.
Spawning was triggered once the light was turned on and was usu-
ally completed within 30 min.2.2. Compounds
All compounds were obtained from Sigma–Aldrich unless
stated otherwise. A series of glycol ether metabolites, namely
methoxyacetic acid (MAA, cat. No. 194557), ethoxyacetic acid
(EAA, cat. No. 137111), butoxyacetic acid (BAA, Tokyo ChemicalIndustries, Zwijndrecht, Belgium, cat. No. B1467), phenoxyacetic
acid (PAA, cat. No. 77740), butoxyethoxyacetic acid (BEAA, Tokyo
Chemical Industries, cat. No. D2491) and methoxyethoxyacetic
acid (MEAA, cat. No. 407011) were selected. Furthermore, ethylene
glycol monomethyl ether (EGME, cat. No. 360503) and ethylene
glycol monoethyl ether (EGEE, cat. No. 128082), the two parent
compounds of MAA and EAA, respectively, were tested. These com-
pounds were diluted directly in Dutch Standard Water (DSW;
demineralized water supplemented with NaHCO3 (100 mg/l),
KHCO3 (20 mg/l), CaCl22H2O (200 mg/l), and MgSO47H2O
(180 mg/l) and then aerated for 24 h at 27 C).
In addition, a series of six triazole derivatives was tested: ﬂusi-
lazole (FLU, cat. No. 45753), hexaconazole (HEX, cat. No. 34348),
cyproconazole (CYP, mixture of diastereomers, cat. No. 46068),
triadimefon (TDF, cat. No. 45693), myclobutanil (MYC, cat. No.
34360) and triticonazole (TTC, cat. No. 34172). All triazoles were
dissolved in DMSO and further diluted in DSW (0.2% DMSO vol/
vol ﬁnal concentration). 0.2% DMSO was used as solvent control.
As negative and positive control 3,4-dichloroaniline (cat. No.
35827) was used at concentrations of 6.2 and 48.4 lM respectively,
to verify the sensitivity of the embryos. At the lower concentration
embryos developed normally as opposed to the high exposure
which caused coagulation of all embryos within 24 h. Sensitivity
of the embryos remained the same during all tests (data not shown).
The pH of all test media ranged from or was adjusted to 7.4–8.4,
and O2-concentration was at least 6.5 mg/l before and after the test.
2.3. Exposure
Fertilized eggs were collected 30 min after spawning (approxi-
mately 2–8 batches per test) and rinsed a few times in DSW before
exposure. Fertilization rate of the batch of eggs used was at least
90%. After rinsing, the eggs were evenly distributed among the test
concentrations. Hereafter, embryos within the 4- to 32-cell stage
were selected and transferred to a 24-well plate containing 2 ml
of test medium per well. One embryo was transferred to one well
and 10 embryos per test concentration were used. Each experi-
ment was performed in triplicate. Four control embryos were pres-
ent on each plate and if necessary solvent controls were included.
Embryos were kept in an incubator at 26.5 C ± 1 C with a photo-
period of 14 h light: 10 h dark.
2.4. Evaluation of embryos
Morphological evaluation of the embryos was performed at
72 h post fertilization (hpf) using a Leica Labovert FS microscope.
GMS was recorded using the GMS system (Fig. 1). This scoring sys-
tem is developed similar to the one used for rat WEC (Brown and
Fabro, 1981) and comprises the normal development of a zebraﬁsh
embryo up to 72 hpf as described by Kimmel et al. (1995). The
semi-quantitative assessment of speciﬁc developmental endpoints
supports standardization of the evaluation. An experimental em-
bryo is compared to the reference embryo in the scoring matrix
and receives points for each developmental hallmark dependent
on its stage of development. All deviations, for instance incomplete
detachment of the tail, will result in a lower point score which cor-
responds to a certain extent of developmental retardation. Malfor-
mations and other teratogenic effects are separately recorded as
present or absent according to the list in Table 1. The test was con-
sidered valid if <10% of the control embryos showed coagulation or
effects.
2.5. Benchmark concentration and benchmark dose determination
The results of the ZET data were analyzed using the benchmark
dose (BMD) approach (Slob, 2002), in which the benchmark
Fig. 1. General morphology scoring system showing normal development of a zebraﬁsh embryo up to 72 h post fertilization with different scores assigned to speciﬁc
developmental endpoints in time.
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was calculated using a ﬁtted dose–response curve.
For the tested compounds a decrease of 5% in GMS was deﬁned
as the BMR for calculating the corresponding BMC (BMCGMS). This
BMR level was arbitrarily selected to obtain the concentration re-
lated to the threshold of effect outside the normal variation. The
model used to ﬁt these data was selected according to a previously
described method (Piersma et al., 2008; Slob, 2002). Brieﬂy, in this
procedure a nested family of concentration–response curves with
an increasing number of parameters is ﬁtted and the log likelihoodof each model is calculated to determine its goodness of ﬁt. The
model with the lowest number of parameters which gave the best
ﬁt was selected to calculate the BMCGMS.
The BMC for teratogenicity (BMCT), with teratogenicity deﬁned
as the fraction of embryos with one or more teratogenic effects,
was calculated with a BMR deﬁned as a 5% increase in the fraction
of affected embryos. This level was also arbitrarily selected in the
same manner as for the BMCGMS. For these quantal data, four mod-
els with statistically similar goodness of ﬁt were ﬁtted, namely
log–logistic, Weibull, log-probit and gamma. The model with the
Table 2
Benchmark concentrations for the endpoints GMS and teratogenicity for different
glycol ethers in the ZET.
Glycol ethers BMCGMSa (mM) BMCTb (mM)
MAA 2.7 (1.9–3.6) 4.6 (2.5–5.7)
EAA 3.1 (2.6–3.7) 2.9 (2.2–3.5)
BAA – –
PAA – –
MEAA – –
BEAA – –
EGME – –
EGEE – –
– No effect.
a Benchmark concentration for general morphology score at a 5% benchmark
response.
b Benchmark concentration for teratogenicity at a 5% benchmark response.
Table 1
List of teratogenic effects scored in zebraﬁsh embryos.
Pericardial edema
Yolk sac edema
Eye edema
Malformation of the head
Malformation of sacculi/otoliths
Malformation of tail
Malformation of heart
Modiﬁed chorda structure
Scoliosis
Rachischisis
Yolk deformation
Effects are scored as present or absent.
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same class are expected to have similar mechanisms of action.
Therefore, based on the analysis of individual compounds the most
conservative model per class of compounds was selected for ﬁnal
BMC calculation (DPR-MT1, 2004; DPR-MT2, 2004). For the group
of glycol ethers and their metabolites the gamma model was used,
as for the triazole anti-fungals the Weibull model was selected to
ﬁt the concentration–response curves.
2.6. In vivo data
A literature survey was performed for each of the glycol ether
compounds to map their embryotoxic and developmental toxic ef-
fects in vivo. For the glycol ether metabolites, which are regarded
as the proximate teratogens (Brown et al., 1984; Giavini et al.,
1993; Yonemoto et al., 1984), no relevant literature on in vivo stud-
ies was available and for that reason studies using the parent glycol
ethers were included. Furthermore, only studies with multiple
exposure times, multiple doses and an oral exposure route were ta-
ken into account.
Model selection and BMD derivation was performed in the same
way for the in vivo data as was done for the ZET data. The endpoints
for in vivo data were fetal body weight (BMDBW) and incidence of
malformations (BMDM). The corresponding BMRs were set at 10%
decrease in fetal body weight and a 10% increase in incidence of
malformations, which were judged to be close to the threshold of
detection of adverse effects. Fetal body weight was analyzed as a
continuous endpoint and the incidence of malformations as a
quantal one.
The effect levels for the in vivo as well as for the ZET data were
chosen such that they could be estimated within each of the se-
lected studies and could be distinguished from the background
variation. This approach has previously been used by Piersma
et al. (2008). Proast curve-ﬁtting software was used to derive the
BMCs and BMDs.
In vivo data for all the triazole anti-fungals was obtained from
the Toxicity Reference Database (ToxRefDB (US Environmental
Protection Agency)). This database provides detailed toxicity data
including the results of developmental toxicity studies. The devel-
opmental lowest effect levels (dLEL) of the triazoles were used to
compare with our ZET data. In vivo and ZET data were correlated
using Proast software and a maximum correlation was calculated
using the model which ﬁtted a straight line on a double logarith-
mic scale (y = axb) (Bokkers and Slob, 2005; Piersma et al., 2008).
3. Results
3.1. Glycol ethers – ZET
After conducting the ZET, BMCGMS and BMCT were derived for
the group of glycol ethers and their metabolites (Table 2). Resultsshowed that only MAA and EAA resulted in a concentration-depen-
dent decrease in GMS, with a BMCGMS of 2.7 and 3.1 mM, respec-
tively (Fig. 2(A and B)). The other glycol ether metabolites did
not reduce the GMS as compared to the controls up to the highest
concentration that could be tested. Furthermore, embryos exposed
to MAA and EAA showed comparable dysmorphology after expo-
sure (Fig. 3, left panel). Several teratogenic effects were observed
following exposure, among which heart, head and tail malforma-
tions, including scoliosis, were the most pronounced. The corre-
sponding BMCT for MAA and EAA were 4.6 and 2.9 mM,
respectively. Unlike their metabolites, the parent compounds
EGME and EGEE did not show any effect on general morphology
and teratogenicity.
3.2. Glycol ethers – in vivo
From literature, in vivo studies were selected to calculate the
benchmark dose for body weight effects (BMDBW) and for malfor-
mations (BMDM) for the different compounds. To facilitate compar-
ison, selection criteria included similarity of species, exposure
route and exposure timing and duration. Table 3 presents the
details of the studies selected and the calculated BMDBW and
BMDM. Rat gavage studies with complete prenatal developmental
exposure were predominant, although for some compounds only
a mouse study or a rat dietary exposure could be identiﬁed. EGME
and EGEE, parent compounds of MAA and EAA (also indicated in
Table 3), appeared as the most potent compounds in vivo both with
regard to fetal body weight reduction and malformations. The
respective BMDsBW were 0.2 and 0.7 mmol/kg bw/day and the
respective BMDsM were 0.5 and 0.8 mmol/kg bw/day. EGME and
EGEE were followed by EGBE and diEGME (the parent compound
of MEAA), which had similar BMDs. However, for EGBE it should
be noted that the conﬁdence interval exceeded the highest concen-
tration tested, and its developmental effects occurred at doses
toxic to pregnant female rats. For EGPE just one study was avail-
able from which only a BMDBW could be derived. However, it must
be noted that the slight decrease in fetal body weight that was ob-
served occurred at the relatively high dose of 4000 mg/kg bw/day
and that the BMDBW exceeded the highest concentration tested.
For diEGBE (BEAA) no observed effects subsequent to exposure
were described in vivo.
3.3. Triazoles – ZET
In Fig. 2(C and D) the concentration–response curves for the six
triazoles tested are presented. Using these curves the BMCGMS was
determined. In this study, FLU and HEX were the most potent tri-
azole anti-fungals tested (Table 4). A reduction of 5% in GMS was
found for FLU at 4.8 lM and for HEX at 7.0 lM. CYP, TDF and
Fig. 2. Concentration–response curves of general morphology score and teratogenicity (fraction of embryos with at least one teratogenic effect) scored at 72 h post
fertilization for the glycol ether metabolites (A and B) and 1,2,4-triazoles (C and D).
Fig. 3. Representative pictures of zebraﬁsh embryos at 72 h post fertilization exposed to DSW (control) and glycol ether metabolites (left panel), and DMSO (control) and
1,2,4-triazoles (right panel).
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between 27.7 and 30.2 lM. TTC showed minor effects only in thehighest concentration tested and was indicated as the least potent
triazole with a BMCGMS of 80.5. Furthermore, it should be noted
Table 3
Developmental toxicity of glycol ethers in rodents.
Parent compound Species and
strain
Route Days Dose (mg/kg bw/day) BMDBWa
(mmol/kg bw/day)
BMDMb
(mmol/kg bw/day)
References
EGME (MAA) SD rat Diet GD7–18 0–16–31–73 0.2 (0.1–0.3) 0.5 (0.5–0.7) Nelson et al. (1989)
EGEE (EAA) Wistar rat Diet GD1–21 0–12–23–46–93–186–372 0.7 (0.6–0.8) 0.8 (0.8–0.9) Stenger et al. (1971)
EGBE (BAA) CD-1 mice Diet GD8–14 0–350–650–1000–1500–2000 12.0 (7.9–24.4c) 12.8 (9.7–45.1c) Wier et al. (1987)
diEGME (MEAA) SD rat Gavage GD7–16 0–1000–1495–2235–3345 16.3 (11.9–20.6) 10.4 (4.3–14.5) Hardin et al. (1986)
EGPE (PAA) CD-1 mice Diet 7 PM–B 0–400–2000–4000 30.7c (24.4–41.5c) NA Heindel et al. (1990)
diEGBE (BEAA) Wistar rat Diet GD0–20 0–25–115–633 No effect No effect Ema et al. (1988)
PM = premating, GD = gestational day, B = birth, NA = data not available.
Metabolite is indicated between brackets.
a Benchmark dose for fetal bodyweight reduction at a benchmark response of 10%.
b Benchmark dose for the increase in fetal malformations at a benchmark response of 10%.
c Exceeding highest dose tested.
Table 4
Benchmark concentrations for the endpoints GMS and teratogenicity for different
triazoles in the ZET.
Triazoles BMCGMSa (lM) BMCTb (lM) dLELc (lmol/kg bw/day)
FLU 4.8 (4.3–5.4) 8.1 (5.4–11.3) 1.3
HEX 7.0 (6.1–7.9) 10.1 (7.1–19.0) 8.0
CYP 27.7 (22.3–34.7) 19.8 (8.4–29.7) 41.1
TDF 29.2 (23.1–37.5) 6.6 (3.5–12.3) 170.2
MYC 30.2 (28.0–32.5) 51.4 (25.8–53.8) 1083.9
TTC 80.5 (66.7–101.5d) 40.0 (16.2–96.2) 3146.5
a Benchmark concentration for general morphology score at a 5% benchmark
response.
b Benchmark concentration for teratogenicity at a 5% benchmark response.
c dLEL: lowest effect level for any developmental effect derived from the
ToxRefDB.
d Exceeding highest concentration tested.
Fig. 4. In vivo dLEL values plotted against in vitro BMC values for GMS. Line shows
correlation with y = axb. Slope b = 2.6 and correlation r2 = 0.88.
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est tested concentration.
Comparable patterns of teratogenic effects were observed for all
triazoles, however, at different concentrations, indicative of differ-
ences in potency. TDF most potently induced teratogenic effects,
showing a 5% increase in the fraction of affected embryos at a con-
centration of 6.6 lM. Next in line were FLU and HEX, with a BMCT
of 8.1 and 10.1 lM, respectively, followed by CYP with a BMCT of
19.8 lM. MYC was found to have a BMCT of 51.4 lM. TTC showed
a BMCT of 40.0 lM, however, even at the highest tested concentra-
tion TTC did not cause 100% teratogenicity in contrast to the other
compounds.
Despite the different concentrations at which the various tria-
zoles exerted their effects, the patterns of teratogenic effects ap-
peared very similar (Fig. 3, right panel), mostly comprising head
and heart malformations, scoliosis, yolk deformation and edema
in exposed embryos.
3.4. Triazoles – in vivo
Similar to our ZET results, the lowest effect level for develop-
mental effects (dLEL), as obtained from the ToxRefDB, showed that
FLU is the most potent triazole antifungal (1.3 lmol/kg bw/day)
(Table 4). In addition, the dLEL of HEX is in the same order of
magnitude at 8 lmol/kg bw/day. CYP, TDF and MYC have lower
potencies with a dLEL of 41.1, 170.2 and 1083.9 lmol/kg bw/day,
respectively. TTC showed to be the least potent compound
(3146.5 lmol/kg bw/day). In general, the ranking of these com-
pounds with the ZET is comparable to the ranking in vivo.
Fig. 4 shows the correlation between the in vivo dLEL and the
ZET BMCGMS for the triazoles. On a double logarithmic scale a
straight line can be ﬁtted with a slope of 2.6 and with a maximum
correlation (r2) of 0.88.4. Discussion
In this study we employed a novel evaluation method for mor-
phologically screening zebraﬁsh embryo development. The GMS
system was based on the normal developmental hallmarks of a
zebraﬁsh embryo up to 72 hpf. Scores were assigned to well-
deﬁned and easily observable morphological endpoints characterized
by a distinct developmental progression in time which leads to a
standardized and semi-quantitative assessment of (mal)develop-
ment. The GMS system has a similar design as the scoring system
developed for WEC (Brown and Fabro, 1981) albeit that GMS
includes fewer endpoints and more limited score levels. Different
methods for evaluation of zebraﬁsh embryos are available, for
instance the one developed by Nagel (2002). They score twenty-one
endpoints in a binomial way to derive the LC50 and EC50 (Nagel,
2002). In addition, the teratogenic index (LC50/EC50) can be calcu-
lated to give an indication of the teratogenicity of a compound
(Nagel, 2002; Selderslaghs et al., 2009). However, the severity of
effects for the endpoints used is not taken into account. Brannen
et al. (2010) use a more quantitative assessment of the zebraﬁsh
embryos by assigning points to the evaluated parameters, and
several endpoints are measured or counted, giving quantitative
results, which is quite labor intensive. Our system uses a semi-
quantitative assessment, which is relatively faster, and measures
development in time as well as teratogenic effects. Our results
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opment and allows us to discriminate between compounds within
a class of chemicals, with different embryotoxic potencies.
Within the class of glycol ether compounds, our results indicate
that MAA and EAA were the most potent glycol ether metabolites
inducing growth retardation. The ranking of the metabolites based
on BMCGMS was found to be in good agreement with the in vivo
BMDBW of the parent compounds. The same held true for malfor-
mations in the ZET and in vivo for these compounds; in the ZET
MAA and EAA both most potently caused teratogenic effects, and
in vivo both EGME and EGEE were also found to be the most potent
teratogenic compounds. These compounds decreased the GMS in
developing zebraﬁsh in a concentration-dependent manner. Fur-
thermore, they induced several distinct teratogenic effects. The dif-
ferences in relative potencies of metabolites in vitro and their
parent compounds in vivo can be explained at least in part by dif-
ferences in in vivo kinetics of the compounds. After intravenous or
intraperitoneal injection in the rat the elimination half-life was
estimated to be 14–18.6 h for MAA and 7.6–10.1 h for EAA (Aas-
moe and Aarbakke, 1997; Aasmoe et al., 1999). The slower elimina-
tion of MAA suggests increased exposure of the embryo to this
compound compared to EAA, which might explain its relatively
higher embryotoxic potency.
In addition, other studies showed growth retardation and mal-
formations in embryos exposed in utero to MAA and EGME (Brown
et al., 1984; Feuston et al., 1990; Hanley et al., 1984; Nagano et al.,
1981). Skeletal defects were among the most frequently found
malformations caused by MAA and EGME (Brown et al., 1984;
Hanley et al., 1984; Nagano et al., 1981; Sleet et al., 1988; Stenger
et al., 1971), which are comparable to one of the most frequent
malformations observed in this study in the ZET, namely tail
malformations including scoliosis.
The relative potencies in the ZET were also comparable to
observations in in vitro tests. In the embryonic stem cell test
MAA and EAA were also found to be the most potent compounds
of the glycol ether metabolites in inhibiting the differentiation of
stem cells into beating cardiomyocytes (de Jong et al., 2009). In
addition, a concentration-related decrease in total morphological
score, indicating growth retardation, was observed in the rat
WEC after exposure to MAA and EAA (Giavini et al., 1993; Rawlings
et al., 1985; Yonemoto et al., 1984), which is comparable to our
results for GMS in the ZET.
In vivo, parent compounds EGME and EGEE are thought to exert
their effects via their alcohol dehydrogenase (ADH) mediated
embryotoxic metabolites MAA and EAA, respectively (Brown
et al., 1984; Giavini et al., 1993). However, in the ZET these parent
compounds do not seem to have an effect, which indicates a lack of
metabolism. In WEC the rat embryo is also not affected by the par-
ent compounds probably due to a lack of ADH activity (Yonemoto
et al., 1984). For zebraﬁsh embryos it has been found that ADH8A
and ADH8B mRNA were expressed as early as 24 hpf (Reimers
et al., 2004), which is part of the time window in the ZET. However,
ADH8A showed considerably lower expression in 24–96 hpf zebra-
ﬁsh embryos compared to adults, suggestive of a limited ability to
metabolize compounds during the ﬁrst hours of development
(Reimers et al., 2004).
In contrast to MAA and EAA, BAA and PAA did not show any
effects in the ZET. In vivo, their parent compounds EGBE and EGPE
appear to reduce fetal body weight in mice. However, for EGPE
the BMDBW exceeded the highest concentration that was tested,
which was indicated as the maximally tolerated dose (4000 mg/
kg bw/day) (Heindel et al., 1990). In rabbits, dermally exposed to
EGPE, neither embryotoxicity nor teratogenic effects were ob-
served (Scortichini et al., 1987), which concurs with our results
in the ZET as well. EGBE also induced some teratogenic effects
in vivo. However, the observed effects occurred at maternally toxicdoses, which might explain the lower body weight of the fetuses at
these doses (Wier et al., 1987). Thus, the absence of observed ef-
fects in the zebraﬁsh embryo, in which maternal toxicity does
not play a role, indeed may be in line with inactivity of EGBE and
EGPE in mouse and rabbit embryos. This ﬁnding stipulates the
advantage of the ZET, in that effects are always directly on the em-
bryo and no uncertainty can arise about possible maternally med-
iated embryotoxicity.
Also BEAA and MEAA did not change the GMS and the fraction
of embryos with teratogenic effects compared to the controls. As
well as in the ZET, the parent compound of BEAA did not have an
effect in vivo in rats (Ema et al., 1988; Nolen et al., 1985) or rabbits
(Nolen et al., 1985) exposed during gestation. For diEGME, in vivo
effects were found in contrast to no observed effects in zebraﬁsh
embryos exposed to MEAA. In a developmental toxicity study,
Hardin et al. observed effects of diEGME in rats after exposure from
GD7–16 (Hardin et al., 1986). However, the potency of diEGME was
considerably lower than that of EGME and EGEE which might be
the reason why we did not measure any effects in the ZET with
MEAA.
In summary, for the chemical class of glycol ethers and their
metabolites, the ZET was able to distinguish and rank compounds
as to their embryotoxic potencies in vivo, although the ZET appar-
ently lacked the required metabolic activation capacity and the
interpretation was based on prior knowledge of proximate embry-
otoxic metabolites in vivo.
The ranking of triazole derivatives based on BMCGMS showed
that FLU and HEX were the most potent compounds in the ZET.
These compounds were also found to be the most potent in vivo,
with FLU and HEX having the lowest dLEL. FLU and HEX were
followed by the less potent CYP, TDF and MYC. These three
compounds had a similar potency in the ZET. The least potent
triazole derivative in the ZET as well as in vivo was TTC. In vivo,
the triazole ranking was comparable to the ranking in the ZET,
however, the relative potencies were different. These variations
may be explained by differences in uptake, distribution and elimi-
nation between the models. Anyway, the overall correlation be-
tween the in vivo and ZET data appeared to be good (r2 = 0.88).
Based on teratogenicity, TDF was found to be very potent in the
ZET, comparable with FLU and HEX, which is in contrast with the
ranking in vivo. However, the number of effects observed in one
embryo caused by FLU and HEX was higher than the number of
effects of TDF at similar low doses. Mainly heart malformations
or pericardial edema were found after exposure to TDF, in contrast
to head malformations, yolk sac edema and yolk deformations
which were observed after exposure to FLU and HEX.
In a developmental toxicity study using mice, craniofacial mal-
formations and axial skeletal defects were found following expo-
sure to TDF (Menegola et al., 2005). In addition, Machera et al.
showed delayed ossiﬁcation of the skull bones and cleft palate in
rat embryos exposed during gestation to CYP (Machera, 1995).
X. laevis studies showed also craniofacial malformations in embryos
exposed to triazoles; mainly branchial arch malformations were
found after exposure to TDF, which precedes craniofacial defects
(Groppelli et al., 2005; Papis et al., 2006). Similar defects were also
found in rat embryos exposed to FLU (Menegola et al., 2001). It can
be concluded that in the ZET all tested triazoles, except TTC,
showed teratogenic effects of a comparable nature, although at
different doses, indicative of differences in potency. In addition,
the potency ranking appeared very favorably comparable to the
in vivo potencies, especially when considering that the correlation
was based on toxicodynamics only.
As stated before, the teratogenic effects found in one class of
chemicals appeared very similar between the compounds in that
class. Moreover, as shown in Fig. 3, the effects found in glycol ether
exposed zebraﬁsh embryos were very different from the effects
752 S.A.B. Hermsen et al. / Toxicology in Vitro 25 (2011) 745–753observed in zebraﬁsh embryos exposed to the triazoles. This is
indicative of different mechanisms of embryotoxic action between
these classes. For instance, MAA appears to have an endocrine dis-
ruptive effect; it potentiates the ligand-dependent activity of mul-
tiple nuclear receptors by targeting a common pathway in nuclear
receptor-mediated signaling (Henley and Korach, 2006). The tria-
zoles are thought to inhibit the cytochrome P450 isoenzyme
CYP26 (Menegola et al., 2006). In early development of zebraﬁsh
these enzymes are already present (Dobbs-McAuliffe et al., 2004;
Gu et al., 2005). It is possible that in the zebraﬁsh embryo the dif-
ferent mechanisms of action of these classes of compounds may
lead to different patterns of malformations. Thus, in addition to
embryotoxic potency determination, the ZET allows the identiﬁca-
tion of speciﬁc malformation patterns that may be used to further
elucidate mechanisms of embryotoxicity.
The wealth of transgenic zebraﬁsh models in addition to siRNA,
morpholino and transciptomics approaches currently being devel-
oped adds to the elaborate toolbox available for the study of embry-
otoxicity in the zebraﬁsh embryo model (Bill et al., 2009; Hill et al.,
2005; Nasevicius and Ekker, 2000; Weil et al., 2009; Yang et al.,
2007, 2009), and could be employed in combination with the GMS.
In this study, the category approach was applied, which as-
sumes that a series of compounds with similar structure will show
coherent trends in their toxicological effects, generally associated
with a common mechanism of action (Hefter et al., 1999; OECD,
2007). If the in vitro ranking of the compounds within a class cor-
responds to the in vivo ranking there is a high likelihood that
embryotoxicity of new compounds within the same class can be
reliably predicted with the test system. We demonstrated that
the ranking of glycol ether alkoxy metabolites and 1,2,4-triazole
derivatives with the ZET are very comparable to the in vivo ranking.
This approach may help to further assess the applicability domain
of the ZET regarding additional chemical classes.Conﬂict of interest
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